Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$104.94
-1.2%
$112.00
$89.67
$121.64
$182.56B0.765.56 million shs6.15 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$380.37
-2.1%
$385.34
$254.85
$403.76
$134.92B1.391.60 million shs1.11 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$148.95
+0.2%
$153.70
$143.13
$175.97
$358.47B0.557.44 million shs7.09 million shs
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$195.63
+2.0%
$191.74
$133.13
$200.94
$561.78B1.139.27 million shs9.22 million shs
Raymond James stock logo
RJF
Raymond James
$125.39
+0.1%
$124.00
$84.06
$131.19
$26.21B1.031.06 million shs959,455 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-1.16%-1.27%-5.03%-6.66%-4.82%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-2.13%+2.33%-1.70%-1.70%+26.14%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.15%-1.46%-1.79%-4.78%-7.51%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
+2.00%+1.96%-1.44%+11.92%+43.41%
Raymond James stock logo
RJF
Raymond James
+0.10%+2.32%-3.54%+11.86%+45.21%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9884 of 5 stars
3.35.04.24.52.22.52.5
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.7896 of 5 stars
2.45.00.04.03.22.53.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8992 of 5 stars
3.23.04.23.93.02.51.9
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
4.5663 of 5 stars
2.35.02.52.13.12.51.9
Raymond James stock logo
RJF
Raymond James
4.8696 of 5 stars
2.15.02.53.52.53.33.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5015.78% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.76
Moderate Buy$396.174.15% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8618.06% Upside
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2.65
Moderate Buy$192.05-1.83% Downside
Raymond James stock logo
RJF
Raymond James
2.20
Hold$126.220.66% Upside

Current Analyst Ratings

Latest RJF, JPM, ISRG, JNJ, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/25/2024
Raymond James stock logo
RJF
Raymond James
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$131.00 ➝ $126.00
4/25/2024
Raymond James stock logo
RJF
Raymond James
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$145.00 ➝ $141.00
4/25/2024
Raymond James stock logo
RJF
Raymond James
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$132.00 ➝ $131.00
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
4/19/2024
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$425.00 ➝ $435.00
4/19/2024
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$412.00 ➝ $421.00
4/19/2024
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$440.00 ➝ $436.00
4/19/2024
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$365.00 ➝ $375.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
(Data available from 5/9/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.55$6.30 per share16.65$22.36 per share4.69
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$7.12B18.94$5.41 per share70.32$38.03 per share10.00
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.65B4.19$13.64 per share10.92$28.57 per share5.21
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$239.43B2.35$20.97 per share9.33$104.45 per share1.87
Raymond James stock logo
RJF
Raymond James
$12.99B2.02$9.27 per share13.52$48.40 per share2.59

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2132.6920.502.5513.96%20.18%10.60%7/18/2024 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.80B$5.5468.6666.044.9327.16%12.91%11.22%7/18/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.2913.632.4645.26%36.70%15.07%7/18/2024 (Estimated)
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$49.55B$16.5611.8112.102.3820.05%17.79%1.34%7/12/2024 (Estimated)
Raymond James stock logo
RJF
Raymond James
$1.74B$8.2715.1612.410.8512.72%18.24%2.37%7/24/2024 (Estimated)

Latest RJF, JPM, ISRG, JNJ, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2024Q1 24
Raymond James stock logo
RJF
Raymond James
$2.32$2.31-$0.01$2.40$3.15 billion$3.12 billion    
4/18/2024Q1 24
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.3990$1.50+$0.1010$0.81$1.87 billion$1.89 billion      
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
4/12/2024Q1 2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.18$4.63+$0.45$4.82$40.90 billion$41.93 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.10%+12.31%68.54%53 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.33%+5.70%30.92%63 Years
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.602.35%+4.00%27.78%2 Years
Raymond James stock logo
RJF
Raymond James
$1.801.44%+32.21%21.77%1 Years

Latest RJF, JPM, ISRG, JNJ, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
3/19/2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
quarterly$1.152.37%4/4/20244/5/20244/30/2024
2/23/2024
Raymond James stock logo
RJF
Raymond James
Quarterly$0.451.52%3/28/20244/1/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.11
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
5.55
4.61
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.94
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
1.29
0.92
0.92
Raymond James stock logo
RJF
Raymond James
0.37
0.99
0.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
71.55%
Raymond James stock logo
RJF
Raymond James
83.83%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
13,676354.71 million351.87 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.40 billionOptionable
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
309,9262.87 billion2.85 billionOptionable
Raymond James stock logo
RJF
Raymond James
18,000209.03 million188.67 millionOptionable

RJF, JPM, ISRG, JNJ, and ABT Headlines

SourceHeadline
Raymond James boosts Northeast presence with $800M teamRaymond James boosts Northeast presence with $800M team
investmentnews.com - May 8 at 8:57 PM
Raymond James (NYSE:RJF) Insider James E. Bunn Sells 11,095 Shares of StockRaymond James (NYSE:RJF) Insider James E. Bunn Sells 11,095 Shares of Stock
americanbankingnews.com - May 7 at 5:24 AM
Raymond James (NYSE:RJF) Insider Sells $1,380,661.80 in StockRaymond James (NYSE:RJF) Insider Sells $1,380,661.80 in Stock
insidertrades.com - May 7 at 4:13 AM
What to Expect From Raymond James Next CEOWhat to Expect From Raymond James' Next CEO
thinkadvisor.com - May 6 at 7:53 PM
Insider Selling: Raymond James (NYSE:RJF) Insider Sells 11,095 Shares of StockInsider Selling: Raymond James (NYSE:RJF) Insider Sells 11,095 Shares of Stock
marketbeat.com - May 6 at 5:41 PM
Natixis Advisors L.P. Boosts Stake in Raymond James (NYSE:RJF)Natixis Advisors L.P. Boosts Stake in Raymond James (NYSE:RJF)
marketbeat.com - May 4 at 10:17 AM
Raymond James (NYSE:RJF) Receives Consensus Recommendation of "Hold" from AnalystsRaymond James (NYSE:RJF) Receives Consensus Recommendation of "Hold" from Analysts
americanbankingnews.com - May 4 at 4:06 AM
Raymond James CEOs on criticisms that led to growth, tech and more advisorsRaymond James' CEOs on criticisms that led to growth, tech and more advisors
financial-planning.com - May 2 at 9:34 PM
Raymond James (NYSE:RJF) CEO Steven M. Raney Sells 4,174 Shares of StockRaymond James (NYSE:RJF) CEO Steven M. Raney Sells 4,174 Shares of Stock
americanbankingnews.com - April 30 at 4:06 AM
Steven M. Raney Sells 4,174 Shares of Raymond James (NYSE:RJF) StockSteven M. Raney Sells 4,174 Shares of Raymond James (NYSE:RJF) Stock
insidertrades.com - April 30 at 4:04 AM
Raymond James (NYSE:RJF) Shares Sold by Yousif Capital Management LLCRaymond James (NYSE:RJF) Shares Sold by Yousif Capital Management LLC
marketbeat.com - April 29 at 6:16 AM
Q1 2025 EPS Estimates for Raymond James (NYSE:RJF) Lifted by Seaport Res PtnQ1 2025 EPS Estimates for Raymond James (NYSE:RJF) Lifted by Seaport Res Ptn
americanbankingnews.com - April 29 at 2:58 AM
Raymond James (NYSE:RJF) Stake Trimmed by California Public Employees Retirement SystemRaymond James (NYSE:RJF) Stake Trimmed by California Public Employees Retirement System
marketbeat.com - April 27 at 6:25 AM
Wealth Enhancement Group Acquires $502 Million Hybrid RIAWealth Enhancement Group Acquires $502 Million Hybrid RIA
msn.com - April 27 at 4:14 AM
Raymond James notches wins in the Sun Belt with advisor additionsRaymond James notches wins in the Sun Belt with advisor additions
investmentnews.com - April 26 at 6:13 PM
Raymond James Financial, Inc. (RJF) Q2 2024 Earnings Call TranscriptRaymond James Financial, Inc. (RJF) Q2 2024 Earnings Call Transcript
seekingalpha.com - April 26 at 1:12 PM
Raymond James Financial, Inc. (NYSE:RJF) Q2 2024 Earnings Call TranscriptRaymond James Financial, Inc. (NYSE:RJF) Q2 2024 Earnings Call Transcript
finance.yahoo.com - April 26 at 1:12 PM
Raymond James wealth unit posts record profits, assetsRaymond James' wealth unit posts record profits, assets
financial-planning.com - April 26 at 8:12 AM
Raymond James Financial Second Quarter 2024 Earnings: In Line With ExpectationsRaymond James Financial Second Quarter 2024 Earnings: In Line With Expectations
finance.yahoo.com - April 26 at 8:12 AM
Raymond James’ incoming CEO shrugs off DOL ruleRaymond James’ incoming CEO shrugs off DOL rule
investmentnews.com - April 25 at 7:51 PM
Raymond James: Still Bullish Considering In-Line Results And Positive OutlookRaymond James: Still Bullish Considering In-Line Results And Positive Outlook
seekingalpha.com - April 25 at 7:51 PM
Story behind Raymond James CEOs path to record client assetsStory behind Raymond James CEO's path to record client assets
finance.yahoo.com - April 25 at 7:51 PM
Breaking Down Raymond James Finl: 5 Analysts Share Their ViewsBreaking Down Raymond James Finl: 5 Analysts Share Their Views
markets.businessinsider.com - April 25 at 2:50 PM
Raymond James (NYSE:RJF) Given New $126.00 Price Target at TD CowenRaymond James (NYSE:RJF) Given New $126.00 Price Target at TD Cowen
marketbeat.com - April 25 at 2:29 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Intuitive Surgical logo

Intuitive Surgical

NASDAQ:ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
JPMorgan Chase & Co. logo

JPMorgan Chase & Co.

NYSE:JPM
JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services to consumers and small businesses through bank branches, ATMs, and digital and telephone banking. The CIB segment provides investment banking products and services, including corporate strategy and structure advisory, and equity and debt market capital-raising services, as well as loan origination and syndication; payments; and cash and derivative instruments, risk management solutions, prime brokerage, and research. This segment also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The CB segment provides financial solutions, including lending, payments, investment banking, and asset management to small and midsized companies, local governments, nonprofit clients, and large corporations, as well as investors, developers, and owners of multifamily, office, retail, industrial, and affordable housing properties. The AWM segment offers multi-asset investment management solutions in equities, fixed income, alternatives, and money market funds to institutional clients and retail investors; and retirement products and services, brokerage, custody, estate planning, lending, deposits, and investment management products to high net worth clients. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.
Raymond James logo

Raymond James

NYSE:RJF
Raymond James Financial, Inc., a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments. The Private Client Group segment provides securities brokerage services, including the sale of equities, mutual funds, fixed income products, and insurance products to their individual clients; and borrowing and lending of securities to and from other broker-dealers, financial institutions, and other counterparties. The Capital Markets segment offers securities brokerage, trading, and research services to institutions with a focus on sale of the United States and Canadian equities and fixed income products; and manages and participates in underwritings, merger and acquisition services, and public finance activities. The Asset Management segment engages in the operations of Eagle, the Eagle Family of Funds, Cougar, the asset management operations of Raymond James & Associates, trust services of Raymond James Trust, and other fee-based asset management programs. The RJ Bank segment provides corporate loans, SBL, tax-exempt loans, and residential loans. The Other segment engages in private equity activities, including various direct and third party private equity investments; and private equity funds. Raymond James Financial, Inc. was founded in 1962 and is based in St. Petersburg, Florida.